Fred Hutchinson Cancer Center: Myelodysplastic Syndromes trials
The registry lists 108 Myelodysplastic Syndromes studies with Fred Hutchinson Cancer Center as lead sponsor. 8 are open to participants now and 50 have results posted.
Phase 1 33Phase 2 77Phase 3 3No phase 16(a study in two phases counts in both)
Studies
Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Fludarabine Phosphate, Low-Dose Total-Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine, Mycophenolate Mofetil, Donor Lymphocyte Infusion in Treating Patients With Hematopoietic CancerCompletedNCT00006251Phase 1/2
- Bone Marrow Transplantation in Treating Patients With Hematologic CancerCompletedNCT00005854Phase 2
- Biological Therapy in Treating Patients With Myelodysplastic SyndromeCompletedNCT00005853Phase 2
- Bone Marrow Transplantation in Treating Patients With Hematologic CancerCompletedNCT00005804Phase 2
- Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerCompletedNCT00005799Not applicable
- Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Nonmalignant Hematologic DiseaseCompletedNCT00003913Phase 2
- Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell TransplantationCompletedNCT00003887Phase 2
- Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow TransplantWithdrawnNCT00002790Phase 1/2